(PharmaNewsWire.Com, February 26, 2018 ) Asia Pacific Cartilage Regeneration Market was worth USD 67.44 million in 2017 and is projected to be growing at a CAGR of 13.1%, to touch USD 124.80 million by 2022. Cartilage is a kind of connective tissue which seams bones together. Cartilage tissue is vital because of the flexibility and steadiness of movement it provides. It is found in the human body in parts like ear, nose, throat, rib cage and between the bones of the back.
Bone and Cartilage are both specialised systems of connective tissue and are made up of cells in an extracellular matrix. Cartilage is thin, avascular, flexible and shows resistance to compressive forces. Hyaline Cartilage is the most widespread type of cartilage and makes up the embryonic skeleton.
The growth of the Asia Pacific Cartilage Regeneration Market is driven by factors such as the availability of huge population base with the consequent increased incidence of joint and bone disorders, growing frequency of injuries related to sports and other accidents. The increase in obese population is also among the major drivers of the market. Unfavourable reimbursement policies coupled with the high cost of cartilage regeneration are among the major restraints faced by the market.
The Asia Pacific Cartilage Regeneration Market is segmented on the basis of the Type of Treatment, Application and Geography. Based on the Type of Treatment used, the Cartilage Regeneration market is divided into Cell Based Approaches and Non-Cell Based Approaches. The Cell based Approaches are further divided into Chondrocyte Transplantation, Stem Cells and Growth Factor Technology. Non-cell based approach is further classified into Tissue Scaffolds and Cell-free composites. Based on Application, the Cartilage Regeneration Market is segmented into Hyaline Cartilage Regeneration and Fibrocartilage Regeneration.
The Asia Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Factors such as growing elderly population with immunity and blood disorders, and growing disposable incomes due to emerging economies in countries such as India and China are expected to lead the growth of the market in this region. Asia Pacific is a fast developing Cartilage Regeneration Market which is expected to face a market boom once the costs of treatment become more feasible. Availability of humongous untapped markets and enormous population base are projected to drive market growth in the future, in the Asia-Pacific Cartilage Regeneration Market.
The significant players in the Asia Pacific Cartilage Regeneration Market include Zimmer Biomet Holdings, Inc. (U.S.), Vericel Corporation (U.S.), Smith & Nephew plc (U.K.), Osiris Therapeutics, Inc. (U.S.), and Arthrex Inc. (U.S.).
About Market Data Forecast Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
